Organic iodine compound (for X-ray attenuation)

Organic iodine compounds used for X-ray attenuation are not biological targets such as receptors, enzymes, or transporters. Instead, they are contrast agents—chemicals administered to patients during radiographic procedures like CT scans and angiography to enhance the visibility of internal structures. These compounds contain covalently bound iodine atoms attached to organic molecules; the high atomic number of iodine (53) makes them highly effective at absorbing X-rays through photoelectric absorption, especially when the incident energy is near the K-edge of iodine (33.2 keV)[2][5][6]. This property increases image contrast between tissues containing the agent and surrounding tissues. The effectiveness of these agents can be influenced by molecular structure—for example, interatomic distances between covalently linked iodines can modulate absorbance efficiency[1]. Common clinical examples include iohexol, iodixanol, and ioversol[5]. While essential for diagnostic imaging, these agents are not considered therapeutic targets themselves. They do not participate in signal transduction or other cellular processes but serve a physical function in medical imaging. Notable safety concerns include rare allergic-like reactions and risks associated with renal impairment; absolute contraindications exist for patients with prior severe reactions to these agents[2]. Because "X-ray attenuation via organic iodine compound" refers broadly to a class of chemical agents rather than a specific molecular target or receptor involved in disease biology or drug action pathways—and because it is not itself a protein/gene/therapeutic target—the entry is marked as incorrect for structured therapeutic target databases.

Other names

Iodinated contrast agentIodinated contrast mediaOrganic iodinated compound

Increases X-ray attenuation via photoelectric absorption due to high atomic number of iodine[2][5]